Reactive oxygen species, antioxidants, and the mammalian thioredoxin system1 1This review is based on the licentiate thesis “Thioredoxin reductase—interactions with the redox active compounds 1-chloro-2,4-dinitrobenzene and lipoic acid” by Jonas Nordberg, 2001, Karolinska Institute, Stockholm, ISBN 91-631-1064-4.
Tóm tắt
Từ khóa
Tài liệu tham khảo
Stadtman, 2000, Protein oxidation, Ann. N. Y. Acad. Sci, 899, 191, 10.1111/j.1749-6632.2000.tb06187.x
Ylä-Herttuala, 1999, Oxidized LDL and atherogenesis, Ann. N. Y. Acad. Sci, 874, 134, 10.1111/j.1749-6632.1999.tb09231.x
Cadenas, 2000, Mitochondrial free radical generation, oxidative stress, and aging, Free Radic. Biol. Med, 29, 222, 10.1016/S0891-5849(00)00317-8
Finkel, 2000, Oxidants, oxidative stress and the biology of ageing, Nature, 408, 239, 10.1038/35041687
Furchgott, 1995, A research trail over half a century, Annu. Rev. Pharmacol. Toxicol, 35, 1, 10.1146/annurev.pa.35.040195.000245
Palmer, 1987, Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor, Nature, 327, 524, 10.1038/327524a0
Bogdan, 2001, Nitric oxide and the regulation of gene expression, Trends Cell Biol, 11, 66, 10.1016/S0962-8924(00)01900-0
Kamata, 1999, Redox regulation of cellular signalling, Cell Signal, 11, 1, 10.1016/S0898-6568(98)00037-0
Finkel, 1998, Oxygen radicals and signaling, Curr. Opin. Cell. Biol, 10, 248, 10.1016/S0955-0674(98)80147-6
Sundaresan, 1995, Requirement for generation of H2O2 for platelet-derived growth factor signal transduction, Science, 270, 296, 10.1126/science.270.5234.296
Patel, 2000, Cell signaling by reactive nitrogen and oxygen species in atherosclerosis, Free Radic. Biol. Med, 28, 1780, 10.1016/S0891-5849(00)00235-5
Thannickal, 2000, Reactive oxygen species in cell signaling, Am. J. Physiol. Lung Cell. Mol. Physiol, 279, L1005, 10.1152/ajplung.2000.279.6.L1005
Ghosh, 1999, Effect of oxidative DNA damage in promoter elements on transcription factor binding, Nucleic Acids Res, 27, 3213, 10.1093/nar/27.15.3213
Arrigo, 1999, Gene expression and the thiol redox state, Free Radic. Biol. Med, 27, 936, 10.1016/S0891-5849(99)00175-6
Dalton, 1999, Regulation of gene expression by reactive oxygen, Annu. Rev. Pharmacol. Toxicol, 39, 67, 10.1146/annurev.pharmtox.39.1.67
Morel, 1999, Repression of gene expression by oxidative stress, Biochem. J, 342, 481, 10.1042/0264-6021:3420481
Nakamura, 1997, Redox regulation of cellular activation, Annu. Rev. Immunol, 15, 351, 10.1146/annurev.immunol.15.1.351
Sen, 1996, Antioxidant and redox regulation of gene transcription, FASEB J, 10, 709, 10.1096/fasebj.10.7.8635688
Allen, 2000, Oxidative stress and gene regulation, Free Radic. Biol. Med, 28, 463, 10.1016/S0891-5849(99)00242-7
Marshall, 2000, Nitrosation and oxidation in the regulation of gene expression, FASEB J, 13, 1889, 10.1096/fj.00.011rev
Abate, 1990, Redox regulation of fos and jun DNA-binding activity in vitro, Science, 249, 1157, 10.1126/science.2118682
Hirota, 1999, Distinct roles of thioredoxin in the cytoplasm and in the nucleus. A two-step mechanism of redox regulation of transcription factor NF-kappaB, J. Biol. Chem, 274, 27891, 10.1074/jbc.274.39.27891
Galter, 1994, Distinct effects of glutathione disulphide on the nuclear transcription factor kappa B and the activator protein-1, Eur. J. Biochem, 221, 639, 10.1111/j.1432-1033.1994.tb18776.x
Fridovich, 1999, Fundamental aspects of reactive oxygen species, or what’s the matter with oxygen?, Ann. N. Y. Acad. Sci, 893, 13, 10.1111/j.1749-6632.1999.tb07814.x
Halliwell, 1999, Antioxidant defence mechanisms, Free Radic. Res, 31, 261, 10.1080/10715769900300841
Halliwell, 1996, Antioxidants in human health and disease, Annu. Rev. Nutr, 16, 33, 10.1146/annurev.nu.16.070196.000341
Kuppusamy, 1989, Characterization of free radical generation by xanthine oxidase. Evidence for hydroxyl radical generation, J. Biol. Chem, 264, 9880, 10.1016/S0021-9258(18)81740-9
Zimmerman, 1994, Mechanisms of reperfusion injury, Am. J. Med. Sci, 307, 284, 10.1097/00000441-199404000-00009
Kontos, 1985, Appearance of superoxide anion radical in cerebral extracellular space during increased prostaglandin synthesis in cats, Circ. Res, 57, 142, 10.1161/01.RES.57.1.142
McIntyre, 1999, Endothelial function in hypertension, Hypertension, 34, 539, 10.1161/01.HYP.34.4.539
Chae, 1999, Characterization of three isoforms of mammalian peroxiredoxin that reduce peroxides in the presence of thioredoxin, Diabetes Res. Clin. Pract, 45, 101, 10.1016/S0168-8227(99)00037-6
Chae, 1999, Isoforms of mammalian peroxiredoxin that reduce peroxides in presence of thioredoxin, Methods Enzymol, 300, 219, 10.1016/S0076-6879(99)00128-7
Mates, 1999, Antioxidant enzymes and human diseases, Clin. Biochem, 32, 595, 10.1016/S0009-9120(99)00075-2
Harris, 1994, Iron release from ferritin and its sensitivity to superoxide ions differs among vertebrates, Biochem. J, 301, 385, 10.1042/bj3010385
Fridovich, 1997, Superoxide anion radical (O2−•), superoxide dismutases, and related matters, J. Biol. Chem, 272, 18515, 10.1074/jbc.272.30.18515
Rubbo, 2000, Nitric oxide reaction with lipid peroxyl radicals spares alpha-tocopherol during lipid peroxidation. Greater oxidant protection from the pair nitric oxide/alpha-tocopherol than alpha-tocopherol/ascorbate, J. Biol. Chem, 275, 10812, 10.1074/jbc.275.15.10812
Hogg, 1998, Nitric oxide and low-density lipoprotein oxidation, Free Radic. Res, 28, 593, 10.3109/10715769809065815
Beckman, 1996, Nitric oxide, superoxide, and peroxynitrite, Am. J. Physiol, 271, C1424, 10.1152/ajpcell.1996.271.5.C1424
Radi, 2001, Unraveling peroxynitrite formation in biological systems, Free Radic. Biol. Med, 30, 463, 10.1016/S0891-5849(00)00373-7
Halliwell, B. Antioxidants and human disease: a general introduction. Nutr. Rev. 55:S44–459; discussion S49–S52; 1997.
Andrew, 1999, Enzymatic function of nitric oxide synthases, Cardiovasc. Res, 15, 521, 10.1016/S0008-6363(99)00115-7
Kroncke, 2000, Implications of inducible nitric oxide synthase expression and enzyme activity, Antioxid. Redox Signal, 2, 585, 10.1089/15230860050192341
Ignarro, 1990, Haem-dependent activation of guanylate cyclase and cyclic GMP formation by endogenous nitric oxide, Pharmacol. Toxicol, 67, 1, 10.1111/j.1600-0773.1990.tb00772.x
Wink, 1998, Chemical biology of nitric oxide, Free Radic. Biol. Med, 25, 434, 10.1016/S0891-5849(98)00092-6
Arnelle, 1995, NO+, NO, and NO− donation by S-nitrosothiols, Arch. Biochem. Biophys, 318, 179, 10.1006/abbi.1995.1231
Patel, 1996, Nitric oxide-induced inhibition of lung endothelial cell nitric oxide synthase via interaction with allosteric thiols, Am. J. Respir. Cell. Mol. Biol, 15, 410, 10.1165/ajrcmb.15.3.8810647
Zhang, 1998, Thioredoxin overexpression prevents NO-induced reduction of NO synthase activity in lung endothelial cells, Am. J. Physiol, 275, L288
Nikitovic, 1996, S-nitrosoglutathione is cleaved by the thioredoxin system with liberation of glutathione and redox regulating nitric oxide, J. Biol. Chem, 271, 19180, 10.1074/jbc.271.32.19180
Thomas, 1988, Human neutrophil antimicrobial activity, Rev. Infect. Dis, 10, S450, 10.1093/cid/10.Supplement_2.S450
Nauseef, 1999, The NADPH-dependent oxidase of phagocytes, Proc. Assoc. Am. Physicians, 111, 373, 10.1111/paa.1999.111.5.373
Rossi, 1985, Mechanism of production of toxic oxygen radicals by granulocytes and macrophages and their function in the inflammatory process, Pathol. Res. Pract, 180, 136, 10.1016/S0344-0338(85)80161-8
Rosen, 1990, Loss of DNA-membrane interactions and cessation of DNA synthesis in myeloperoxidase-treated Escherichia coli, Proc. Natl. Acad. Sci. USA, 87, 10048, 10.1073/pnas.87.24.10048
Sen, 1998, Redox signaling and the emerging therapeutic potential of thiol antioxidants, Biochem. Pharmacol, 55, 1747, 10.1016/S0006-2952(97)00672-2
Baeuerle, 1994, Function and activation of NF-kappa B in the immune system, Annu. Rev. Immunol, 12, 141, 10.1146/annurev.iy.12.040194.001041
Foletta, 1998, Transcriptional regulation in the immune system, J. Leukoc. Biol, 63, 139, 10.1002/jlb.63.2.139
Kyriakis, 1999, Activation of the AP-1 transcription factor by inflammatory cytokines of the TNF family, Gene Expr, 7, 217
Schreck, 1991, Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1, EMBO J, 10, 2247, 10.1002/j.1460-2075.1991.tb07761.x
Timblin, 1998, GRP78, HSP72/73, and cJun stress protein levels in lung epithelial cells exposed to asbestos, cadmium, or H2O2, Free Radic. Biol. Med, 24, 632, 10.1016/S0891-5849(97)00325-0
Singh, 1995, The effect of active oxygen generated by xanthine/xanthine oxidase on genes and signal transduction in mouse epidermal JB6 cells, Int. J. Cancer, 62, 107, 10.1002/ijc.2910620120
Ozolins, 1997, Oxidative stress regulates the expression and activity of transcription factor activator protein-1 in rat conceptus, J. Pharmacol. Exp. Ther, 280, 1085
Nose, 1991, Transcriptional activation of early-response genes by hydrogen peroxide in a mouse osteoblastic cell line, Eur. J. Biochem, 201, 99, 10.1111/j.1432-1033.1991.tb16261.x
Weichselbaum, 1994, Radiation induction of immediate early genes, Int. J. Radiat. Oncol. Biol. Phys, 30, 229, 10.1016/0360-3016(94)90539-8
Huber, 1987, Escherichia coli thioredoxin stabilizes complexes of bacteriophage T7 DNA polymerase and primed templates, J. Biol. Chem, 262, 16224, 10.1016/S0021-9258(18)47719-8
Saitoh, 1998, Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1, EMBO J, 17, 2596, 10.1093/emboj/17.9.2596
Hirota, 1997, AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1, Proc. Natl. Acad. Sci. USA, 94, 3633, 10.1073/pnas.94.8.3633
Schenk, 1994, Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-B and AP-1, Proc. Natl. Acad. Sci. USA, 91, 1672, 10.1073/pnas.91.5.1672
Åslund, 1999, Regulation of the OxyR transcription factor by hydrogen peroxide and the cellular thiol-disulfide status, Proc. Natl. Acad. Sci. USA, 96, 6161, 10.1073/pnas.96.11.6161
Choi, 2001, Structural basis of the redox switch in the OxyR transcription factor, Cell, 105, 103, 10.1016/S0092-8674(01)00300-2
Carmel-Harel, 2001, Role of thioredoxin reductase in the Yap1p-dependent response to oxidative stress in Saccharomyces cerevisiae, Mol. Microbiol, 39, 595, 10.1046/j.1365-2958.2001.02255.x
Kroemer, 1998, The mitochondrial death/life regulator in apoptosis and necrosis, Annu. Rev. Physiol, 60, 619, 10.1146/annurev.physiol.60.1.619
Cortopassi, 1999, Mitochondria in organismal aging and degeneration, Biochim. Biophys. Acta, 1410, 183, 10.1016/S0005-2728(98)00166-2
Ames, 1993, Oxidants, antioxidants, and the degenerative diseases of aging, Proc. Natl. Acad. Sci. USA, 90, 7915, 10.1073/pnas.90.17.7915
Butterfield, 1998, Structural and functional changes in proteins induced by free radical-mediated oxidative stress and protective action of the antioxidants N-tert-butyl-alpha-phenylnitrone and vitamin E, Ann. N. Y. Acad. Sci, 854, 448, 10.1111/j.1749-6632.1998.tb09924.x
Melov, 2000, Extension of life-span with superoxide dismutase/catalase mimetics, Science, 289, 1567, 10.1126/science.289.5484.1567
Steinberg, 1997, Low density lipoprotein oxidation and its pathobiological significance, J. Biol. Chem, 272, 20963, 10.1074/jbc.272.34.20963
Halliwell, 1993, The role of oxygen radicals in human disease, with particular reference to the vascular system, Haemostasis, 23, 118
Frei, 1999, On the role of vitamin C and other antioxidants in atherogenesis and vascular dysfunction, Proc. Soc. Exp. Biol. Med, 222, 196, 10.1046/j.1525-1373.1999.d01-136.x
Stadtman, 1998, Reactive oxygen-mediated protein oxidation in aging and disease, Drug Metab. Rev, 30, 225, 10.3109/03602539808996310
Lowther, 2000, Thiol-disulfide exchange is involved in the catalytic mechanism of peptide methionine sulfoxide reductase, Proc. Natl. Acad. Sci. USA, 97, 6463, 10.1073/pnas.97.12.6463
Yost, 1973, An iron-containing superoxide dismutase from Escherichia coli, J. Biol. Chem, 248, 4905, 10.1016/S0021-9258(19)43649-1
Weisiger, 1973, Mitochondrial superoxide dismutase, J. Biol. Chem, 248, 4793, 10.1016/S0021-9258(19)43735-6
Melov, 1998, A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase, Nat. Genet, 18, 159, 10.1038/ng0298-159
Das, 1997, Elevation of manganese superoxide dismutase gene expression by thioredoxin, Am. J. Respir. Cell Mol. Biol, 17, 713, 10.1165/ajrcmb.17.6.2809
Ohlemiller, 1999, Targeted deletion of the cytosolic Cu/Zn-superoxide dismutase gene (Sod1) increases susceptibility to noise-induced hearing loss, Audiol. Neurootol, 4, 237, 10.1159/000013847
Rosen, 1993, Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis, Nature, 362, 59, 10.1038/362059a0
Orrell, 2000, Amyotrophic lateral sclerosis, Neuromuscul. Disord, 10, 63, 10.1016/S0960-8966(99)00071-1
Wiedau-Pazos, 1996, Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis, Science, 271, 515, 10.1126/science.271.5248.515
Marklund, 1982, Human copper-containing superoxide dismutase of high molecular weight, Proc. Natl. Acad. Sci. USA, 79, 7634, 10.1073/pnas.79.24.7634
Lombard, 2000, Reaction of the desulfoferrodoxin from Desulfoarculus baarsii with superoxide anion. Evidence for a superoxide reductase activity, J. Biol. Chem, 275, 115, 10.1074/jbc.275.1.115
Lombard, 2000, Superoxide reductase as a unique defense system against superoxide stress in the microaerophile Treponema pallidum, J. Biol. Chem, 275, 7021, 10.1016/S0021-9258(19)61474-2
Aebi, 1974, Catalase, 673
Kirkman, 1999, Mechanisms of protection of catalase by NADPH. Kinetics and stoichiometry, J. Biol. Chem, 274, 13908, 10.1074/jbc.274.20.13908
Kim, 1988, The isolation and purification of a specific “protector” protein which inhibits enzyme inactivation by a thiol/Fe(III)/O2 mixed-function oxidation system, J. Biol. Chem, 263, 4704, 10.1016/S0021-9258(18)68840-4
Poole, 2000, AhpF can be dissected into two functional units, Biochemistry, 39, 6602, 10.1021/bi000405w
Miranda-Vizuete, 2000, The mitochondrial thioredoxin system, Antioxid. Redox Signal, 4, 801, 10.1089/ars.2000.2.4-801
Zhou, 2000, Mouse peroxiredoxin V is a thioredoxin peroxidase that inhibits p53-induced apoptosis, Biochem. Biophys. Res. Commun, 268, 921, 10.1006/bbrc.2000.2231
Zhang, 1997, Thioredoxin peroxidase is a novel inhibitor of apoptosis with a mechanism distinct from that of Bcl-2, J. Biol. Chem, 272, 30615, 10.1074/jbc.272.49.30615
Butterfield, 1999, From cytoprotection to tumor suppression, Antioxid. Redox Signal, 4, 385, 10.1089/ars.1999.1.4-385
Ursini, 1995, Diversity of glutathione peroxidases, Methods Enzymol, 252, 38, 10.1016/0076-6879(95)52007-4
de Haan, 1998, Mice with a homozygous null mutation for the most abundant glutathione peroxidase, Gpx1, show increased susceptibility to the oxidative stress-inducing agents paraquat and hydrogen peroxide, J. Biol. Chem, 273, 22528, 10.1074/jbc.273.35.22528
Ursini, 1999, Dual function of the selenoprotein PHGPx during sperm maturation, Science, 285, 1393, 10.1126/science.285.5432.1393
Pfeifer, H.; Conrad, M.; Roethlein, D.; Kyriakopoulos, A.; Brielmeier, M. Bornkamm, G. W.; Behne, D.; Identification of a specific sperm nuclei selenoenzyme necessary for protamine thiol cross-linking during sperm maturation. FASEB J. Express Article 10.1096/fj.00-0655fje; 2001.
Dreher, 1997, Expression of selenoproteins in various rat and human tissues and cell lines, J. Trace Elem. Med. Biol, 11, 83, 10.1016/S0946-672X(97)80031-4
Björnstedt, 1994, The thioredoxin and glutaredoxin systems are efficient electron donors to human plasma glutathione peroxidase, J. Biol. Chem, 269, 29382, 10.1016/S0021-9258(18)43889-6
Rundlöf, 2000, Prominent expression of the selenoprotein thioredoxin reductase in the medullary rays of the rat kidney and thioredoxin reductase mRNA variants differing at the 5′ untranslated region, Biochem. J, 347, 661, 10.1042/0264-6021:3470661
Epp, 1983, The refined structure of the selenoenzyme glutathione peroxidase at 0.2-nm resolution, Eur. J. Biochem, 133, 51, 10.1111/j.1432-1033.1983.tb07429.x
Jones, 1981, Metabolism of hydrogen peroxide in isolated hepatocytes, Arch. Biochem. Biophys, 210, 505, 10.1016/0003-9861(81)90215-0
Kelner, 1990, Alteration of endogenous glutathione peroxidase, manganese superoxide dismutase, and glutathione transferase activity in cells transfected with a copper-zinc superoxide dismutase expression vector. Explanation for variations in paraquat resistance, J. Biol. Chem, 265, 10872, 10.1016/S0021-9258(19)38527-8
Ho, 1997, Mice deficient in cellular glutathione peroxidase develop normally and show no increased sensitivity to hyperoxia, J. Biol. Chem, 272, 16644, 10.1074/jbc.272.26.16644
Armstrong, 1997, Structure, catalytic mechanism, and evolution of the glutathione transferases, Chem. Res. Toxicol, 10, 2, 10.1021/tx960072x
van Bladeren, 2000, Glutathione conjugation as a bioactivation reaction, Chem. Biol. Interact, 129, 61, 10.1016/S0009-2797(00)00214-3
Williams, 1992, 121
Kanzok, 2000, The thioredoxin system of the malaria parasite Plasmodium falciparum. Glutathione reduction revisited, J. Biol. Chem, 275, 40180, 10.1074/jbc.M007633200
Kanzok, 2001, Substitution of the thioredoxin system for glutathione reductase in Drosophila melanogaster, Science, 291, 643, 10.1126/science.291.5504.643
Holmgren, 2000, Antioxidant function of thioredoxin and glutaredoxin systems, Antioxid. Redox Signal, 2, 811, 10.1089/ars.2000.2.4-811
Holmgren, 1989, Thioredoxin and glutaredoxin systems, J. Biol. Chem, 264, 13963, 10.1016/S0021-9258(18)71625-6
Holmgren, 1995, Thioredoxin and thioredoxin reductase, Methods Enzymol, 252, 199, 10.1016/0076-6879(95)52023-6
Gleason, 1988, Thioredoxin and related proteins in procaryotes, FEMS Microbiol. Rev, 4, 271, 10.1111/j.1574-6968.1988.tb02747.x
Arnér, 1999, Preparation and assay of mammalian thioredoxin and thioredoxin reductase, Methods Enzymol, 300, 226, 10.1016/S0076-6879(99)00129-9
Balcewicz-Sablinska, 1991, Human eosinophil cytotoxicity-enhancing factor. II. Multiple forms synthesized by U937 cells and their relationship to thioredoxin/adult T cell leukemia-derived factor, J. Immunol, 147, 2170, 10.4049/jimmunol.147.7.2170
Ericson, 1992, Secretion of thioredoxin after in vitro activation of human B cells, Lymphokine Cytokine Res, 11, 201
Nakamura, 1992, Expression and growth-promoting effect of adult T-cell leukemia-derived factor. A human thioredoxin homologue in hepatocellular carcinoma, Cancer, 69, 2091, 10.1002/1097-0142(19920415)69:8<2091::AID-CNCR2820690814>3.0.CO;2-X
Nakamura, 2001, Chronic elevation of plasma thioredoxin, Proc. Natl. Acad. Sci. USA, 98, 2688, 10.1073/pnas.041624998
Pekkari, 2000, Truncated thioredoxin is a mitogenic cytokine for resting human peripheral blood mononuclear cells and is present in human plasma, J. Biol. Chem, 275, 37474, 10.1074/jbc.M001012200
Pekkari, 2001, Truncated thioredoxin (Trx80) induces production of interleukin-12 and enhances CD14 expression in human monocytes, Blood, 97, 3184, 10.1182/blood.V97.10.3184
Rosen, 1995, A CD4+ T cell line-secreted factor, growth promoting for normal and leukemic B cells, identified as thioredoxin, Int. Immunol, 7, 625, 10.1093/intimm/7.4.625
Sahaf, 2000, Secretion of 10-kDa and 12-kDa thioredoxin species from blood monocytes and transformed leukocytes, Antioxid. Redox Signal, 2, 717, 10.1089/ars.2000.2.4-717
Matthews, 1992, Thioredoxin regulates the DNA binding activity of NF-kappa B by reduction of a disulphide bond involving cysteine 62, Nucleic Acids Res, 20, 3821, 10.1093/nar/20.15.3821
Taniguchi, 1996, A novel promoter sequence is involved in the oxidative stress-induced expression of the adult T-cell leukemia-derived factor (ADF)/human thioredoxin (Trx) gene, Nucleic Acids Res, 24, 2746, 10.1093/nar/24.14.2746
Spyrou, 1997, Cloning and expression of a novel mammalian thioredoxin, J. Biol. Chem, 272, 2936, 10.1074/jbc.272.5.2936
Miranda-Vizuete, 2001, Characterization of Sptrx, a novel member of the thioredoxin family specifically expressed in human spermatozoa, J. Biol. Chem, 276, 31567, 10.1074/jbc.M101760200
Reichard, 1993, From RNA to DNA, why so many ribonucleotide reductases?, Science, 260, 1773, 10.1126/science.8511586
Lundström, 1990, Protein disulfide-isomerase is a substrate for thioredoxin reductase and has thioredoxin-like activity, J. Biol. Chem, 265, 9114, 10.1016/S0021-9258(19)38819-2
Arnér, 2000, Physiological functions of thioredoxin and thioredoxin reductase, Eur. J. Biochem, 267, 6102, 10.1046/j.1432-1327.2000.01701.x
Becker, 2000, Thioredoxin reductase as a pathophysiological factor and drug target, Eur. J. Biochem, 267, 6118, 10.1046/j.1432-1327.2000.01703.x
Reddy, 1999, Lens-specific regulation of the thioredoxin-1 gene, but not thioredoxin-2, upon in vivo photochemical oxidative stress in the Emory mouse, Biochem. Biophys. Res. Commun, 265, 345, 10.1006/bbrc.1999.1691
Aota, 1996, Protection against reperfusion-induced arrhythmias by human thioredoxin, J. Cardiovasc. Pharmacol, 27, 727, 10.1097/00005344-199605000-00016
Rubartelli, 1995, High rates of thioredoxin secretion correlate with growth arrest in hepatoma cells, Cancer Res, 55, 675
Nakamura, 1996, Elevation of plasma thioredoxin levels in HIV-infected individuals, Int. Immunol, 8, 603, 10.1093/intimm/8.4.603
Saito, 1996, Increased expression of human thioredoxin/adult T cell leukemia-derived factor in Sjogren’s syndrome, Arthritis Rheum, 39, 773, 10.1002/art.1780390509
Yoshida, 1999, Involvement of thioredoxin in rheumatoid arthritis, J. Immunol, 163, 351, 10.4049/jimmunol.163.1.351
Gasdaska, 1994, The predicted amino acid sequence of human thioredoxin is identical to that of the autocrine growth factor human adult T-cell derived factor (ADF), Biochim. Biophys. Acta, 1218, 292, 10.1016/0167-4781(94)90180-5
Rubartelli, 1992, Secretion of thioredoxin by normal and neoplastic cells through a leaderless secretory pathway, J. Biol. Chem, 267, 24161, 10.1016/S0021-9258(18)35742-9
Biguet, 1994, Thioredoxin increases the proliferation of human B-cell lines through a protein kinase C-dependent mechanism, J. Biol. Chem, 269, 28865, 10.1016/S0021-9258(19)61987-3
Wakasugi, 1990, Adult T-cell leukemia-derived factor/thioredoxin, produced by both human T-lymphotropic virus type I- and Epstein-Barr virus-transformed lymphocytes, acts as an autocrine growth factor and synergizes with interleukin 1 and interleukin 2, Proc. Natl. Acad. Sci. USA, 87, 8282, 10.1073/pnas.87.21.8282
Yodoi, 1991, ADF, a growth-promoting factor derived from adult T cell leukemia and homologous to thioredoxin, Adv. Cancer Res, 57, 381, 10.1016/S0065-230X(08)61004-0
Schenk, 1996, Thioredoxin as a potent costimulus of cytokine expression, J. Immunol, 156, 765, 10.4049/jimmunol.156.2.765
Bertini, 1999, Thioredoxin, a redox enzyme released in infection and inflammation, is a unique chemoattractant for neutrophils, monocytes, and T cells, J. Exp. Med, 189, 1783, 10.1084/jem.189.11.1783
Miller, 2000, Trafficking of neutrophils across airway epithelium is dependent upon both thioredoxin- and pertussis toxin-sensitive signaling mechanisms, J. Leukoc. Biol, 68, 201, 10.1189/jlb.68.2.201
Nakamura, 1994, Adult T cell leukemia-derived factor/human thioredoxin protects endothelial F-2 cell injury caused by activated neutrophils or hydrogen peroxide, Immunol. Lett, 42, 75, 10.1016/0165-2478(94)90038-8
Kim, 2001, Hemin-induced activation of the thioredoxin gene by Nrf2. A differential regulation of the antioxidant responsive element by a switch of its binding factors, J. Biol. Chem, 276, 18399, 10.1074/jbc.M100103200
Sen, 2000, Cellular thiols and redox-regulated signal transduction, Curr. Top. Cell. Regul, 36, 1, 10.1016/S0070-2137(01)80001-7
Wei, 2000, Thioredoxin nuclear translocation and interaction with redox factor-1 activates the activator protein-1 transcription factor in response to ionizing radiation, Cancer Res, 60, 6688
Tanaka, 1997, Induction and nuclear translocation of thioredoxin by oxidative damage in the mouse kidney, Lab. Invest, 77, 145
Gromer, 1999, News and views on thioredoxin reductases, Redox Rep, 4, 221, 10.1179/135100099101534936
Holmgren, 1977, Bovine thioredoxin system. Purification of thioredoxin reductase from calf liver and thymus and studies of its function in disulfide reduction, J. Biol. Chem, 252, 4600, 10.1016/S0021-9258(17)40204-3
Gladyshev, 1996, Selenocysteine, identified as the penultimate C-terminal residue in human T-cell thioredoxin reductase, corresponds to TGA in the human placental gene, Proc. Natl. Acad. Sci. USA, 93, 6146, 10.1073/pnas.93.12.6146
Tamura, 1996, A new selenoprotein from human lung adenocarcinoma cells, Proc. Natl. Acad. Sci. USA, 93, 1006, 10.1073/pnas.93.3.1006
Zhong, 1998, Rat and calf thioredoxin reductase are homologous to glutathione reductase with a carboxyl-terminal elongation containing a conserved catalytically active penultimate selenocysteine residue, J. Biol. Chem, 273, 8581, 10.1074/jbc.273.15.8581
Sun, 1999, Redox regulation of cell signaling by selenocysteine in mammalian thioredoxin reductases, J. Biol. Chem, 274, 24522, 10.1074/jbc.274.35.24522
Sun, 2001, Selenoprotein oxidoreductase with specificity for thioredoxin and glutathione systems, Proc. Natl. Acad. Sci. USA, 98, 3673, 10.1073/pnas.051454398
Sun, 2001, Heterogeneity within animal thioredoxin reductases. Evidence for alternative first exon splicing, J. Biol. Chem, 276, 3106, 10.1074/jbc.M004750200
Lee, 2000, Mammalian thioredoxin reductase, Proc. Natl Acad. Sci. USA, 97, 2521, 10.1073/pnas.050579797
Zhong, 2000, Essential role of selenium in the catalytic activities of mammalian thioredoxin reductase revealed by characterization of recombinant enzymes with selenocysteine mutations, J. Biol. Chem, 275, 18121, 10.1074/jbc.M000690200
Zhong, 2000, Structure and mechanism of mammalian thioredoxin reductase, Proc. Natl. Acad. Sci. USA, 97, 5854, 10.1073/pnas.100114897
Hill, 1997, Thioredoxin reductase activity is decreased by selenium deficiency, Biochem. Biophys. Res. Commun, 234, 293, 10.1006/bbrc.1997.6618
Marcocci, 1997, Evidence for a functional relevance of the selenocysteine residue in mammalian thioredoxin reductase, Biofactors, 6, 351, 10.1002/biof.5520060305
Berggren, 1997, Cellular thioredoxin reductase activity is regulated by selenium, Anticancer Res, 17, 3377
Buettner, 1999, The Caenorhabditis elegans homologue of thioredoxin reductase contains a selenocysteine insertion sequence (SECIS) element that differs from mammalian SECIS elements but directs selenocysteine incorporation, J. Biol. Chem, 274, 21598, 10.1074/jbc.274.31.21598
Sandalova, 2001, Three-dimensional structure of a mammalian thioredoxin reductase, Proc. Natl. Acad. Sci. USA, 98, 9533, 10.1073/pnas.171178698
Arscott, 1997, The mechanism of thioredoxin reductase from human placenta is similar to the mechanisms of lipoamide dehydrogenase and glutathione reductase and is distinct from the mechanism of thioredoxin reductase from Escherichia coli, Proc. Natl. Acad. Sci. USA, 94, 3621, 10.1073/pnas.94.8.3621
Gromer, 1998, A hypothesis on the catalytic mechanism of the selenoenzyme thioredoxin reductase, Biochem. J, 332, 591, 10.1042/bj3320591
Nordberg, 1998, Mammalian thioredoxin reductase is irreversibly inhibited by dinitrohalobenzenes by alkylation of both the redox active selenocysteine and its neighboring cysteine residue, J. Biol. Chem, 273, 10835, 10.1074/jbc.273.18.10835
Miranda-Vizuete, 1999, cDNA cloning, expression and chromosomal localization of the mouse mitochondrial thioredoxin reductase gene, Biochim. Biophys. Acta, 1447, 113, 10.1016/S0167-4781(99)00129-3
Rigobello, 1998, Purification of mitochondrial thioredoxin reductase and its involvement in the redox regulation of membrane permeability, Free Radic. Biol. Med, 24, 370, 10.1016/S0891-5849(97)00216-5
Björnstedt, 1995, Human thioredoxin reductase directly reduces lipid hydroperoxides by NADPH and selenocystine strongly stimulates the reaction via catalytically generated selenols, J. Biol. Chem, 270, 11761, 10.1074/jbc.270.20.11761
1996
Luthman, 1982, Rat liver thioredoxin and thioredoxin reductase, Biochemistry, 21, 6628, 10.1021/bi00269a003
Arnér, 2000, Measurement of thioredoxin and thioredoxin reductase, 7.4.1, 7414
Ferrari, 1999, The protein disulphide-isomerase family, Biochem. J, 339, 1, 10.1042/0264-6021:3390001
Lundstrom-Ljung, 1995, Two resident ER-proteins, CaBP1 and CaBP2, with thioredoxin domains, are substrates for thioredoxin reductase, FEBS Lett, 357, 305, 10.1016/0014-5793(94)01386-F
Hope, 1991, Neuronal NADPH diaphorase is a nitric oxide synthase, Proc. Natl. Acad. Sci. USA, 88, 2811, 10.1073/pnas.88.7.2811
Schmidt, 1992, Ca2+/calmodulin-dependent NO synthase type I, Biochemistry, 31, 3243, 10.1021/bi00127a028
Andersson, 1996, NK-lysin, a disulfide-containing effector peptide of T-lymphocytes, is reduced and inactivated by human thioredoxin reductase. Implication for a protective mechanism against NK-lysin cytotoxicity, J. Biol. Chem, 271, 10116, 10.1074/jbc.271.17.10116
Holmgren, 1980, Enzymatic reduction of alloxan by thioredoxin and NADPH-thioredoxin reductase, Proc. Natl. Acad. Sci. USA, 77, 5149, 10.1073/pnas.77.9.5149
Clark, 1996, Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group, JAMA, 276, 1957, 10.1001/jama.276.24.1957
Wilson, 1992, Effect of methylated forms of selenium on cell viability and the induction of DNA strand breakage, Biochem. Pharmacol, 43, 1137, 10.1016/0006-2952(92)90622-P
Jiang, 2001, Caspases as key executors of methyl selenium-induced apoptosis (anoikis) of DU-145 prostate cancer cells, Cancer Res, 61, 3062
Ip, 1998, Lessons from basic research in selenium and cancer prevention, J. Nutr, 128, 1845, 10.1093/jn/128.11.1845
Kumar, 1992, Selenite is a substrate for calf thymus thioredoxin reductase and thioredoxin and elicits a large non-stoichiometric oxidation of NADPH in the presence of oxygen, Eur. J. Biochem, 207, 435, 10.1111/j.1432-1033.1992.tb17068.x
Ganther, 1971, Reduction of the selenotrisulfide derivative of glutathione to a persulfide analog by glutathione reductase, Biochemistry, 10, 4089, 10.1021/bi00798a013
Björnstedt, 1992, Selenodiglutathione is a highly efficient oxidant of reduced thioredoxin and a substrate for mammalian thioredoxin reductase, J. Biol. Chem, 267, 8030, 10.1016/S0021-9258(18)42403-9
Björnstedt, 1997, Selenium and the thioredoxin and glutaredoxin systems, Biomed. Environ. Sci, 10, 271
May, 1999, Is ascorbic acid an antioxidant for the plasma membrane?, FASEB J, 9, 995, 10.1096/fasebj.13.9.995
Buettner, 1993, The pecking order of free radicals and antioxidants, Arch. Biochem. Biophys, 300, 535, 10.1006/abbi.1993.1074
Sies, 1992, Antioxidant functions of vitamins. Vitamins E and C, beta-carotene, and other carotenoids, Ann. N. Y. Acad. Sci, 669, 7, 10.1111/j.1749-6632.1992.tb17085.x
Chopra, 1999, Antioxidants and lipoprotein metabolism, Proc. Nutr. Soc, 58, 663, 10.1017/S0029665199000865
Meister, 1995, Mitochondrial changes associated with glutathione deficiency, Biochim. Biophys. Acta, 1271, 35, 10.1016/0925-4439(95)00007-Q
May, 1998, Ascorbate function and metabolism in the human erythrocyte, Front. Biosci, 3, D1, 10.2741/A262
Mendiratta, 1998, Enzyme-dependent ascorbate recycling in human erythrocytes, Free Radic. Biol. Med, 25, 221, 10.1016/S0891-5849(98)00060-4
May, 1997, Reduction of dehydroascorbate to ascorbate by the selenoenzyme thioredoxin reductase, J. Biol. Chem, 272, 22607, 10.1074/jbc.272.36.22607
May, 1998, Reduction of the ascorbyl free radical to ascorbate by thioredoxin reductase, J. Biol. Chem, 273, 23039, 10.1074/jbc.273.36.23039
May, 1999, Vitamin C recycling and function in human monocytic U-937 cells, Free Radic. Biol. Med, 26, 1513, 10.1016/S0891-5849(99)00017-9
Tamura, 1995, The mutual sparing effects of selenium and vitamin E in animal nutrition may be further explained by the discovery that mammalian thioredoxin reductase is a selenoenzyme, Biofactors, 5, 99
Bustamante, 1998, Alpha-lipoic acid in liver metabolism and disease, Free Radic. Biol. Med, 24, 1023, 10.1016/S0891-5849(97)00371-7
Teichert, 1992, HPLC-methods for determination of lipoic acid and its reduced form in human plasma, Int. J. Clin. Pharmacol. Ther. Toxicol, 30, 511
Reed, 1996, Chemistry and function of lipoic acid, Vol. 14, 99
Scott, 1994, Lipoic and dihydrolipoic acids as antioxidants. A critical evaluation, Free Radic. Res, 20, 119, 10.3109/10715769409147509
Kagan, 1992, Dihydrolipoic acid—a universal antioxidant both in the membrane and in the aqueous phase. Reduction of peroxyl, ascorbyl and chromanoxyl radicals, Biochem. Pharmacol, 44, 1637, 10.1016/0006-2952(92)90482-X
Packer, 1995, alpha-Lipoic acid as a biological antioxidant, Free Radic. Biol. Med, 19, 227, 10.1016/0891-5849(95)00017-R
Handelman, 1994, Alpha-lipoic acid reduction by mammalian cells to the dithiol form, and release into the culture medium, Biochem. Pharmacol, 47, 1725, 10.1016/0006-2952(94)90298-4
Constantinescu, 1995, Reduction and transport of lipoic acid by human erythrocytes, Biochem. Pharmacol, 50, 253, 10.1016/0006-2952(95)00084-D
Haramaki, 1997, Cytosolic and mitochondrial systems for NADH- and NADPH-dependent reduction of alpha-lipoic acid, Free Radic. Biol. Med, 22, 535, 10.1016/S0891-5849(96)00400-5
Pick, 1995, Glutathione reductase and lipoamide dehydrogenase have opposite stereospecificities for alpha-lipoic acid enantiomers, Biochem. Biophys. Res. Commun, 206, 724, 10.1006/bbrc.1995.1102
Arnér, 1996, Efficient reduction of lipoamide and lipoic acid by mammalian thioredoxin reductase, Biochem. Biophys. Res. Commun, 225, 268, 10.1006/bbrc.1996.1165
Watabe, 1999, Mitochondrial thioredoxin reductase in bovine adrenal cortex its purification, properties, nucleotide/amino acid sequences, and identification of selenocysteine, Eur. J. Biochem, 264, 74, 10.1046/j.1432-1327.1999.00578.x
Ernster, 1995, Biochemical, physiological and medical aspects of ubiquinone function, Biochim. Biophys. Acta, 1271, 195, 10.1016/0925-4439(95)00028-3
Xia, 2001, Reduction of ubiquinone by lipoamide dehydrogenase. An antioxidant regenerating pathway, Eur. J. Biochem, 268, 1486, 10.1046/j.1432-1327.2001.02013.x
Beyer, 1990, The participation of coenzyme Q in free radical production and antioxidation, Free Radic. Biol. Med, 8, 545, 10.1016/0891-5849(90)90154-B
Williams, 2000, Thioredoxin reductase two modes of catalysis have evolved, Eur. J. Biochem, 267, 6110, 10.1046/j.1432-1327.2000.01702.x
Lin, 1999, Methylarsenicals and arsinothiols are potent inhibitors of mouse liver thioredoxin reductase, Chem. Res. Toxicol, 12, 924, 10.1021/tx9900775
Gromer, 1998, Human placenta thioredoxin reductase. Isolation of the selenoenzyme, steady state kinetics, and inhibition by therapeutic gold compounds, J. Biol. Chem, 273, 20096, 10.1074/jbc.273.32.20096
Mau, 1990, Inhibition of thioredoxin reductase (E.C. 1.6.4.5.) by antitumor quinones, Free Radic. Res. Commun, 8, 365, 10.3109/10715769009053370
Mau, 1992, Inhibition of cellular thioredoxin reductase by diaziquone and doxorubicin. Relationship to the inhibition of cell proliferation and decreased ribonucleotide reductase activity, Biochem. Pharmacol, 43, 1621, 10.1016/0006-2952(92)90221-4
Schallreuter, 1989, The stereospecific suicide inhibition of human melanoma thioredoxin reductase by 13-cis-retinoic acid, Biochem. Biophys. Res. Commun, 160, 573, 10.1016/0006-291X(89)92471-6
Schallreuter, 1990, The mechanism of action of the nitrosourea anti-tumor drugs on thioredoxin reductase, glutathione reductase and ribonucleotide reductase, Biochim. Biophys. Acta, 1054, 14, 10.1016/0167-4889(90)90199-N
Sasada, 1999, Possible involvement of thioredoxin reductase as well as thioredoxin in cellular sensitivity to cis-diamminedichloroplatinum (II), Free Radic. Biol. Med, 27, 504, 10.1016/S0891-5849(99)00101-X
Arnér, 2001, Analysis of the inhibition of mammalian thioredoxin, thioredoxin reductase and glutaredoxin by cis-diamminedichloroplatinum (II) and its major metabolite the glutathione-platinum complex, Free Radic. Biol. Med, 31, 1170, 10.1016/S0891-5849(01)00698-0
Ma, 2001, Regulation of interferon and retinoic acid induced cell death activation through thioredoxin reductase, J. Biol. Chem, 276, 24843, 10.1074/jbc.M100380200
Hofmann, 1998, Thioredoxin reductase mediates cell death effects of the combination of beta interferon and retinoic acid, Mol. Cell Biol, 18, 6493, 10.1128/MCB.18.11.6493
Arnér, 1995, 1-Chloro-2,4-dinitrobenzene is an irreversible inhibitor of human thioredoxin reductase. Loss of thioredoxin disulfide reductase activity is accompanied by a large increase in NADPH oxidase activity, J. Biol. Chem, 270, 3479, 10.1074/jbc.270.8.3479
Ahmed, 1983, Delayed-type hypersensitivity skin testing. A review, Arch. Dermatol, 119, 934, 10.1001/archderm.119.11.934
Eriksen, 1980, Treatment of the common wart by induced allergic inflammation, Dermatologica, 160, 161, 10.1159/000250490
Stricker, 1993, Pilot study of topical dinitrochlorobenzene (DNCB) in human immunodeficiency virus infection, Immunol. Lett, 36, 1, 10.1016/0165-2478(93)90060-F
Traub, 1997, Topical immune modulation with dinitrochlorobenzene in HIV disease, Dermatology, 195, 369, 10.1159/000245990
Stricker, 1994, Clinical and immunologic evaluation of HIV-infected patients treated with dinitrochlorobenzene, J. Am. Acad. Dermatol, 31, 462, 10.1016/S0190-9622(94)70212-8
Stricker, 1991, Dendritic cells and dinitrochlorobenzene (DNCB), Immunol. Lett, 29, 191, 10.1016/0165-2478(91)90169-B
Happle, 1978, Dinitrochlorobenzene therapy for alopecia areata, Arch. Dermatol, 114, 1629, 10.1001/archderm.114.11.1629
Buckley, 1999, Topical immunotherapy in dermatology, Int. J. Clin. Pract, 53, 130, 10.1111/j.1742-1241.1999.tb11683.x
Schmidt, 1992, Biochemical responses of skin to allergenic and non-allergenic nitrohalobenzenes. Evidence that an NADPH-dependent reductase in skin may act as a prohapten-activating enzyme, Arch. Dermatol. Res, 284, 400, 10.1007/BF00372070
Arnér, 1999, Superoxide production by dinitrophenyl-derivatized thioredoxin reductase—a model for the mechanism and correlation to immunostimulation by dinitrohalobenzenes, Biofactors, 10, 219, 10.1002/biof.5520100220
Engman, 2000, Water-soluble organotellurium compounds inhibit thioredoxin reductase and the growth of human cancer cells, Anticancer Drug Des, 15, 323
Lin, 2001, Arsenicals inhibit thioredoxin reductase in cultured rat hepatocytes, Chem. Res. Toxicol, 14, 305, 10.1021/tx0001878
Smith, 1999, Aurothioglucose inhibits murine thioredoxin reductase activity in vivo, J. Nutr, 129, 194, 10.1093/jn/129.1.194
Seo, 2000, Identification of a new type of mammalian peroxiredoxin that forms an intramolecular disulfide as a reaction intermediate, J. Biol. Chem, 275, 20346, 10.1074/jbc.M001943200
Chrestensen, 2000, Acute cadmium exposure inactivates thioltransferase (Glutaredoxin), inhibits intracellular reduction of protein-glutathionyl-mixed disulfides, and initiates apoptosis, J. Biol. Chem, 275, 26556, 10.1074/jbc.M004097200
Xia, 2001, Solution structure of Escherichia coli glutaredoxin-2 shows similarity to mammalian glutathione-S-transferases, J. Mol. Biol, 310, 907, 10.1006/jmbi.2001.4721
Ohira, 1994, Oxidative stress induces adult T cell leukemia derived factor/thioredoxin in the rat retina, Lab. Invest, 70, 279
Sachi, 1995, Induction of ADF/TRX by oxidative stress in keratinocytes and lymphoid cells, Immunol. Lett, 44, 189, 10.1016/0165-2478(95)00213-O
Das, 1999, Induction of thioredoxin and thioredoxin reductase gene expression in lungs of newborn primates by oxygen, Am. J. Physiol, 276, L530
Rundlöf, 2001, The core promoter of human thioredoxin reductase 1, J. Biol. Chem, 276, 30542, 10.1074/jbc.M101452200
Kimber, 1992, The mechanisms and evaluation of chemically induced allergy, Toxicol. Lett, 64–65, 79, 10.1016/0378-4274(92)90175-J
Aiba, 1997, Dendritic cells differently respond to haptens and irritants by their production of cytokines and expression of co-stimulatory molecules, Eur. J. Immunol, 27, 3031, 10.1002/eji.1830271141
Bellinghausen, 1999, Signals involved in the early TH1/TH2 polarization of an immune response depending on the type of antigen, J. Allergy Clin. Immunol, 103, 298, 10.1016/S0091-6749(99)70505-1
Coutant, 1999, Modulation of the activity of human monocyte-derived dendritic cells by chemical haptens, a metal allergen, and a staphylococcal superantigen, Toxicol. Sci, 52, 189, 10.1093/toxsci/52.2.189
Matsunaga, 1998, Epidermal cytokine mRNA expression induced by hapten differs from that induced by primary irritant in human skin organ culture system, J. Dermatol, 25, 421, 10.1111/j.1346-8138.1998.tb02428.x
Grabbe, 1998, Immunoregulatory mechanisms involved in elicitation of allergic contact hypersensitivity, Immunol. Today, 19, 37, 10.1016/S0167-5699(97)01186-9
Sher, 1992, Role of T-cell derived cytokines in the downregulation of immune responses in parasitic and retroviral infection, Immunol. Rev, 127, 183, 10.1111/j.1600-065X.1992.tb01414.x
Aronica, 1999, Preferential role for NF-kappa B/Rel signaling in the type 1 but not type 2 T cell-dependent immune response in vivo, J. Immunol, 163, 5116, 10.4049/jimmunol.163.9.5116
Uehara, 1984, Diminished contact sensitivity response in vitiliginous skin, Arch. Dermatol, 120, 195, 10.1001/archderm.120.2.195
Hatchome, 1987, Possible functional impairment of Langerhans’ cells in vitiliginous skin. Reduced ability to elicit dinitrochlorobenzene contact sensitivity reaction and decreased stimulatory effect in the allogeneic mixed skin cell lymphocyte culture reaction, Arch. Dermatol, 123, 51, 10.1001/archderm.123.1.51
Schallreuter, K. U.; Moore, J.; Wood, J. M. Tetrahydrobioprotein (6BH4) recycling is inhibited by epidermal H202 accumulation in vitiligo. Abstract presented at “Cellular Implications of Redox Signaling,” February 18–21, 2001, Padova, Italy.
Loffelhardt, 1995, Interaction of alpha-lipoic acid enantiomers and homologues with the enzyme components of the mammalian pyruvate dehydrogenase complex, Biochem. Pharmacol, 50, 637, 10.1016/0006-2952(95)00175-Y
Wang, 1995, Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms, J. Biol. Chem, 270, 9558, 10.1074/jbc.270.16.9558
Moussavi, 1998, Cytokine production by CD4+ and CD8+ T cells in mice following primary exposure to chemical allergens, Int. Arch. Allergy Immunol, 116, 116, 10.1159/000023934
Dearman, 1997, Classification of chemical allergens according to cytokine secretion profiles of murine lymph node cells, J. Appl. Toxicol, 17, 53, 10.1002/(SICI)1099-1263(199701)17:1<53::AID-JAT393>3.0.CO;2-W
Hess, 1995, CD40 function in nonhematopoietic cells. Nuclear factor kappa B mobilization and induction of IL-6 production, J. Immunol, 155, 4588, 10.4049/jimmunol.155.10.4588
Mohamadzadeh, 1994, Enhanced expression of IL-8 in normal human keratinocytes and human keratinocyte cell line HaCaT in vitro after stimulation with contact sensitizers, tolerogens and irritants, Exp. Dermatol, 3, 298, 10.1111/j.1600-0625.1994.tb00292.x
Warbrick, 1999, Analysis of interleukin 12 protein production and mRNA expression in mice exposed topically to chemical allergens, Toxicology, 132, 57, 10.1016/S0300-483X(98)00137-1
Du, 2000, Induction of interleukin-12/p40 by superantigens in macrophages is mediated by activation of nuclear factor-kappaB, Cell Immunol, 199, 50, 10.1006/cimm.1999.1595
Naik, 1999, Human keratinocytes constitutively express interleukin-18 and secrete biologically active interleukin-18 after treatment with pro-inflammatory mediators and dinitrochlorobenzene, J. Invest. Dermatol, 113, 766, 10.1046/j.1523-1747.1999.00750.x
Holliday, 1997, Differential induction of cutaneous TNF-alpha and IL-6 by topically applied chemicals, Am. J. Contact Dermat, 8, 158, 10.1016/S1046-199X(97)90097-X
Manome, 1999, Simple chemicals can induce maturation and apoptosis of dendritic cells, Immunology, 98, 481, 10.1046/j.1365-2567.1999.00916.x
Packer, 1979, Direct observation of a free radical interaction between vitamin E and vitamin C, Nature, 278, 737, 10.1038/278737a0